Exercise-linked FNDC5/irisin rescues synaptic plasticity and memory defects in Alzheimer’s modelsMychael V. Lourenco, Fernanda G. De Felice|Nature Medicine|2018Cited by 913
Soluble amyloid-β oligomers as synaptotoxins leading to cognitive impairment in Alzheimer’s diseaseSérgio T. Ferreira, Fernanda G. De Felice|Frontiers in Cellular Neuroscience|2015Cited by 357
Pro-inflammatory interleukin-6 signaling links cognitive impairments and peripheral metabolic alterations in Alzheimer’s diseaseNatalia M. Lyra e Silva, Fernanda G. De Felice|Translational Psychiatry|2021Cited by 342
Soluble protein oligomers as emerging toxins in alzheimer's and other amyloid diseasesSérgio T. Ferreira, Fernanda G. De Felice|IUBMB Life|2007Cited by 334
The diabetes drug liraglutide reverses cognitive impairment in mice and attenuates insulin receptor and synaptic pathology in a non‐human primate model of Alzheimer's diseaseAndré F. Batista, Fernanda G. De Felice|The Journal of Pathology|2018Cited by 240